Ogloblina O G, Saburova O S, Semenova O A, Belova L A
Biokhimiia. 1994 Jan;59(1):62-8.
Using plasminogen-Sepharose 4B chromatography, a 50-70% reduction in the alpha-2-antiplasmin (alpha-2-AP) content in human and dog blood plasma was reached. The decrease in the alpha-2-AP concentration in human and dog blood plasma markedly enhanced the lysis of fibrin clots formed from the plasma under the action of urokinase and streptokinase. Thus, the lysis of model clots for a definite period of time for human and dog blood plasma depleted for alpha-2-AP by 50-70% required 5-8 and 3-6 times as low urokinase and streptokinase concentrations as those needed for the clot lysis in the native plasma. The decrease in the fibrinogen concentration in human blood plasma caused by plasmosorption on plasminogen-Sepharose enhanced the model fibrin clot lysis by urokinase and streptokinase, however, by no more than 5-10%. Hence, the increased efficiency of plasminogen activators in the given model system can be accounted for by the decline of the antiplasmin potential of the blood plasma.
通过纤溶酶原 - 琼脂糖4B层析法,人及犬血浆中α2 - 抗纤溶酶(α2 - AP)含量降低了50 - 70%。人及犬血浆中α2 - AP浓度的降低显著增强了在尿激酶和链激酶作用下由血浆形成的纤维蛋白凝块的溶解。因此,对于α2 - AP耗尽50 - 70%的人及犬血浆,在一定时间内溶解模型凝块所需的尿激酶和链激酶浓度分别仅为天然血浆中凝块溶解所需浓度的1/5 - 1/8和1/3 - 1/6。纤溶酶原 - 琼脂糖吸附导致人血浆中纤维蛋白原浓度降低,这使得尿激酶和链激酶对模型纤维蛋白凝块的溶解增强,但增强幅度不超过5 - 10%。因此,在给定模型系统中纤溶酶原激活剂效率的提高可归因于血浆抗纤溶能力的下降。